Kura Oncology updates severance terms for CEO and two other executives

Kura Oncology, Inc. disclosed in an 8-K filing that on July 24, 2026, the company signed a revised employment agreement with Troy E. Wilson, Ph.D., J.D., its Chairman, President and Chief Executive Officer, updating certain severance terms.¹ Separately, on July 27, 2026, the company entered into amended employment agreements with Brian Powl, its Chief Commercial Officer, and Kathleen Ford, its Chief Operating Officer, also to modify severance provisions.¹

Under the revised terms for Wilson, if he is terminated without cause or resigns for good reason outside a window tied to a corporate transaction, he would be entitled to a cash lump sum equal to 12 months of his base salary, up to 12 months of COBRA premium payments, and an extended stock option exercise period of up to 12 months.¹ If such termination occurs within 59 days before, on, or within 18 months after a corporate transaction, Wilson's entitlements increase to 24 months of base salary in a lump sum, a cash payment equal to 200% of his target bonus for the year of the transaction, up to 24 months of COBRA coverage, full acceleration of equity awards vesting (with performance awards vesting at target), and an extended option exercise period of up to 12 months.¹

For Powl and Ford, standard severance outside the transaction window includes 12 months of base salary, up to 12 months of COBRA payments, and an extended option exercise period of up to 12 months.¹ Within the transaction window, their terms rise to 18 months of base salary, a payment equal to 150% of target bonus for the transaction year, up to 18 months of COBRA coverage, full acceleration of equity vesting at target for performance awards, and an extended option exercise period of up to 12 months.¹

The filing states that the remaining terms of these agreements are largely unchanged, and complete copies will be filed with the company's quarterly report for the period ending September 30, 2026.¹ The 8-K was signed by Chief Legal Officer Teresa Bair on July 29, 2026.